Can Filtration Technology Advance Culture of Circulating Tumor Cells towards Precision Medicine?
release_n7swuikcu5h3ro3xuh4o5xflhi
References
NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.| Showing 1 - 30 of 37 references (in 77ms) | ||
|---|---|---|
[b0]via fuzzy |
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L. Siegel, Lindsey A. Torre, Ahmedin Jemal 2018 Ca doi:10.3322/caac.21492 pmid:30207593 |
web.archive.org
[PDF]
|
[b1]via fuzzy |
Two Hundred Years of Cancer Research
Vincent T. DeVita, Steven A. Rosenberg 2012 New England Journal of Medicine doi:10.1056/nejmra1204479 pmcid:PMC6293471 pmid:22646510 |
web.archive.org
[PDF]
|
[b2]via grobid |
Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. International Journal of Oncology. 2019 Feb 1;54(2):407-19.
| |
[b3]via grobid |
Dobosz P, Dzieciątkowski T. The intriguing history of cancer immunotherapy. Frontiers in Immunology. 2019 Dec 17;10:2965.
| |
[b4]via fuzzy |
Delivery technologies for cancer immunotherapy
Rachel S. Riley, Carl H. June, Robert Langer, Michael J. Mitchell 2019 Nature reviews. Drug discovery doi:10.1038/s41573-018-0006-z pmcid:PMC6410566 pmid:30622344 |
web.archive.org
[PDF]
|
[b5]via grobid |
Xiang D, Shigdar S, Qiao G, Wang T, Kouzani AZ, Zhou SF, et al. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics. 2015;5(1):23.
| |
[b6]via fuzzy |
Recent advances in cancer early detection and diagnosis: role of nucleic acid based aptasensors
Eman M. Hassan, Maria C. DeRosa 2020 TrAC. Trends in analytical chemistry doi:10.1016/j.trac.2020.115806 | |
[b7]via grobid |
Strickaert A, Saiselet M, Dom G, De Deken X, Dumont JE, Feron O, et al. Cancer heterogeneity is not compatible with one unique cancer cell metabolic map. Oncogene. 2017 May;36(19):2637-42.
| |
[b8]via grobid |
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nature Reviews Clinical Oncology. 2018 Feb;15(2):81.
| |
[b9]via grobid |
Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, et al . Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Research. 2015 Mar 1;75(5):892-901.
| |
[b10]via grobid |
Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Molecular Medicine. 2015 Jan;7(1):1-1.
| |
[b11]via grobid |
Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014 Sep 25;159(1):176-87.
| |
[b12]via grobid |
Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, Lunke S, et al. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut. 2017 Oct 1;66(10):1802-10.
| |
[b13]via grobid |
Zhao P, Zhou W, Liu C, Zhang H, Cheng Z, Wu W, et al. Establishment and Characterization of a CTC Cell Line from Peripheral Blood of Breast Cancer Patient. Journal of Cancer. 2019;10(24):6095-6104.
| |
[b14]via grobid |
Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014 Jul 11;345(6193):216-20.
| |
[b15]via grobid |
Khoo BL, Grenci G, Jing T, Lim YB, Lee SC, Thiery JP, et al. Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment. Science Advances. 2016 Jul 1;2(7):e1600274.
| |
[b16]via grobid |
Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, et al. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget. 2014 Dec;5(23):12383.
| |
[b17]via grobid |
Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014 Jul 11;345(6193):216-20.
| |
[b18]via grobid |
Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy PJ, Assou S, et al. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Scientific Reports. 2018 Oct 29;8(1):1-12.
| |
[b19]via grobid |
Brungs D, Minaei E, Piper AK, Perry J, Splitt A, Carolan M, et al. Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer. Scientific Reports. 2020 Jan 17;10(1):1-13. 21. Goudar VS, Yeh PH, Wu SY, Chu CH, Lu LS, Yang CH, et al. Live circulating tumour cells selection on digitized self-assembled cell array (Digi-saca) chip by in-parallel/in- situ image analysis, cell capture, and cultivation. Sensors and Actuators B: Chemical. 2020 Apr 11:128002.
| |
[b20]via grobid |
Ueki T, Yoshihara A, Teramura Y, Takai M. Fast and selective cell isolation from blood sample by microfiber fabric system with vacuum aspiration. Science and Technology of Advanced Materials. 2016 Dec 1;17(1):807-15.
| |
[b21]via fuzzy |
Dual-antibody Modified PLGA Nanofibers for Specific Capture of Epithelial and Mesenchymal CTCs
Hui Liu, Zhili Wang, Changchong Chen, Ding Pi, Sun Na, Renjun Pei 2019 Colloids and Surfaces B: Biointerfaces doi:10.1016/j.colsurfb.2019.05.031 pmid:31128514 | |
[b22]via grobid |
Xu G, Tan Y, Xu T, Yin D, Wang M, Shen M, et al. Hyaluronic acid-functionalized electrospun PLGA nanofibers embedded in a microfluidic chip for cancer cell capture and culture. Biomaterials Science. 2017;5(4):752- 61.
| |
[b23]via grobid |
Jørgensen ML, Müller C, Sikkersoq M, Nadzieja M, Zhang Z, Su Y, e t al. A melt-electrowritten filter for capture and culture of circulating colon cancer cells. Materials Today Bio. 2020 May 1:100052.
| |
[b24]via grobid |
Khoo BL, Lee SC, Kumar P, Tan TZ, Warkiani ME, Ow SG, et al. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget. 2015 Jun 20;6(17):15578.
| |
[b25]via grobid |
Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM,
| |
[b26]via grobid |
Azizi E, et al. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget. 2014 Dec;5(23):12383-97.
| |
[b27]via grobid |
Khoo BL, Grenci G, Lim YB, Lee SC, Han J, Lim CT. Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device. Nature Protocols. 2018 Jan;13(1):34-58.
| |
[b28]via grobid |
Satelli A, Brownlee Z, Mitra A, Meng QH, Li S. Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule-and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic Response. Clinical Chemistry. 2015 Jan 1;61(1):259-66.
| |
[b29]via fuzzy |
Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid tumors
Artur Kowalik, Magdalena Kowalewska, Stanisław Góźdź 2017 Translational Research: The Journal of Laboratory and Clinical Medicine doi:10.1016/j.trsl.2017.04.002 pmid:28506696 | |
|
| ||